TREATMENT PATTERNS AND OUTCOMES IN THE FRENCH COHORT OF PATIENTS WITH UNRESECTABLE STAGE III OR STAGE IV MELANOMA (MELODY STUDY): A RETROSPECTIVE LONGITUDINAL SURVEY

被引：0
|
作者：
Bedane, C. [1 ]
Leccia, M. T. [2 ]
Sassolas, B. [3 ]
Mansard, S. [4 ]
Guillot, B. [5 ]
Mortier, L. [6 ]
Robert, C. [7 ]
Saiag, P. [8 ]
Truchetet, F. [9 ]
Oukessou, A. [10 ]
Bregman, B. [10 ]
Lebbe, C. [11 ]
机构：
[1] Hop Dupuytren, Limoges, France
[2] Hop Michallon, La Tronche, France
[3] Hop Morvan, Brest, France
[4] Hop Hotel Dieu, Clermont Ferrand, France
[5] Hop St Eloi, Montpellier, France
[6] Hop Claude Huriez, Lille, France
[7] Inst Gustave Roussy, Villejuif, France
[8] Hop Ambroise Pare, Boulogne, France
[9] Hop Beauregard, Thionville, France
[10] Bristol Myers Squibb Co, Rueil Malmaison, France
[11] Hop St Louis, Paris, France
来源：
VALUE IN HEALTH | 2010年 / 13卷 / 07期
关键词：
D O I：
10.1016/S1098-3015(11)72007-1
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A273 / A273
页数：1
相关论文
共 50 条
  • [21] Investigating the patterns of treatment failure in patients with advanced stage III and IV melanoma receiving adjuvant therapy
    Alimohamed, Asrar Iqbal
    Lawless, Aleigha
    Michaud, William
    Sharova, Tatyana
    Rauwerdink, Daan
    Dedeilia, Aikaterini
    Tarantino, Giuseppe
    Sade-Feldman, Moshe
    Liu, David
    Boland, Genevieve Marie
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [22] Neoadjuvant treatment for stage III and IV cutaneous melanoma
    Gorry, Claire
    McCullagh, Laura
    O'Donnell, Helen
    Barrett, Sarah
    Schmitz, Susanne
    Barry, Michael
    Curtin, Kay
    Beausang, Eamon
    Barry, Rupert
    Coyne, Imelda
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2023, (01):
  • [23] Contemporary outcomes in stage III melanoma patients
    Gray, KD
    Xing, Y
    Feng, L
    Huang, X
    Davidson, L
    Gershenwald, JE
    Lee, JE
    Mansfield, PF
    Ross, MI
    Cormier, JN
    ANNALS OF SURGICAL ONCOLOGY, 2006, 13 (02) : 58 - 59
  • [24] Phase II randomized, placebo controlled study of sorafenib in combination with dacarbazine in subjects with unresectable Stage III or Stage IV melanoma
    McDermott, D.
    Sosman, J. A.
    Hodi, F. S.
    Gonzalez, R.
    Linette, G.
    Richards, J.
    Jakub, J. K.
    Beeram, M.
    Patel, K.
    Hersch, E.
    EJC SUPPLEMENTS, 2007, 5 (04): : 396 - 396
  • [25] Treatment of patients with inoperable stage III or stage IV melanoma. Societe francaise de dermatologie
    Guillot, B.
    Charles, J.
    Jeudy, G.
    Cupissol, D.
    Dupuy, A.
    Dutriaux, C.
    Gangloff, D.
    Magne, N.
    Mirabe, X.
    M'Sadek, A.
    Pracht, M.
    Sichel, C.
    Do Outeiro, G.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2018, 145 (6-7): : 413 - 422
  • [26] Treatment of unresectable stage III NSCLC: Real world cohort study and literature review
    Verfaillie, Saartje
    Lambrecht, Maarten
    Berkovic, Patrick
    Dooms, Christophe
    Nackaerts, Kristiaan
    Van de Velde, Anne-Sophie
    Vansteenkiste, Johan
    Wauters, Els
    CANCER TREATMENT AND RESEARCH COMMUNICATIONS, 2023, 36
  • [27] Ipilimumab for stage unresectable III/IV melanoma: Brazilian experience in an expanded access program
    Schmerling, Rafael
    Herchenhorn, Daniel
    Rinck, Jose Augusto
    De Camargo, Veridiana Pires
    Camargo, Johnny
    Serrano, Sergio Vicente
    Azevedo, Sergio Jobim
    Barrios, Carlos H.
    Martina Segalia, Jose Getulio
    Bertoni, Vanessa Dybal
    Buzald, Antonio C.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [28] A phase II single arm study of pazopanib and paclitaxel as first-line treatment for unresectable stage III and stage IV melanoma: Interim analysis.
    Fruehauf, John P.
    Alger, Beverly
    Parmakhtiar, Basmina
    Jakowatz, James G.
    Bettis, Claudette
    Chuang, Tony
    Ein-Gal, Shlomit Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [29] Nab-paclitaxel and bevacizumab as first-line therapy in patients with unresectable stage III and IV melanoma
    Boasberg, P.
    Cruickshank, S.
    Hamid, O.
    O'Day, S.
    Weber, R.
    Spitler, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [30] Factors associated with HCV-stage III/IV fibrosis: A retrospective study of a large cohort of US patients
    Hu, KQ
    Kyulo, NL
    Xia, VW
    Hu, SX
    Hillebrand, DJ
    Yu, CH
    GASTROENTEROLOGY, 2004, 126 (04) : A745 - A745
12345